Skip to main content

Table 1 Patient overview and tumor status

From: Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer

Patient ID Gender Type Primary tumor grade Metastasis resectiona Treatmentb
Patient 1 Female Adenocarcinoma Moderately differentiated 3 months No treatment
Patient 2 Male Adenocarcinoma Moderately differentiated 20 months No treatment
Patient 3 Male Adenocarcinoma Poorly differentiated 10 months XELOXc and Bevacizumab
Patient 4 Female Adenocarcinoma Well differentiated 9 months 5FU, leucovorin, oxaliplatin, bevacizumab
  1. aTime between primary resection and metastasis resection. bTreatment after primary tumor resection. cCapecitabine and oxaliplatin. 5FU, fluorouracil.